Trending Tickers: Telefonica Brasil (NYSE:VIV), VeriFone Systems (NYSE:PAY), Bravo Brio Restaurant Group (NASDAQ:BBRG), Cousins Properties Incorporated (NYSE:CUZ), SciClone Pharmaceuticals (NASDAQ:SCLN)

Equities researchers at RBC Capital began coverage on shares of Telefonica Brasil SA (NYSE:VIV) in a research report issued on Tuesday, reports. The firm set a “sector perform” rating on the stock.Telefonica Brasil, S.A. (NYSE:VIV) belongs to Technology sector. Its net profit margin is 20.40% and weekly performance is -1.01%. On last trading day company shares ended up $21.64. Telefonica Brasil, S.A. (NYSE:VIV) distance from 50-day simple moving average (SMA50) is 9.22%.

Alex Meruelo, together with Meruelo Investment Partners LLC, and certain other affiliates, disclosed an ownership stake of 5.45% in VeriFone Systems, Inc. in a Schedule 13D filing with the Securities and Exchange Commission, dated September 8, 2014. In addition, Mr. Meruelo and Meruelo Investment Partners LLC, delivered the following letter to the board of directors of VeriFone Systems, Inc. (NYSE:PAY). VeriFone Systems, Inc. (NYSE:PAY) shares increased 6.83% in last trading session and ended the day at $37.40. PAY Gross Margin is 38.00% and its return on assets is -9.70%. VeriFone Systems, Inc. (NYSE:PAY) quarterly performance is 2.61%.

On 10 September, Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG) shares moved down -0.07% and was closed at $14.12. BBRG EPS growth in last 5 year was 16.00%. Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG) year to date (YTD) performance is -13.21%.

Cousins Properties Incorporated (NYSE:CUZ) has signed five new leases totaling 157,279 square feet at Colorado Tower in downtown Austin, TX. Leasing at the 373,000 square-foot, Class-A office development is now 95 percent, up from 51 percent on June 30, 2014. Cousins Properties Incorporated (NYSE:CUZ) ended the last trading day at $12.88. Company weekly volatility is calculated as 1.39%and price to cash ratio as 449.88. Cousins Properties Incorporated (NYSE:CUZ) showed a weekly performance of -0.62%.

SciClone Pharmaceuticals (NASDAQ:SCLN) CFO Lan Xie sold 36,468 shares of the stock on the open market in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $6.97, for a total value of $254,181.96. SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) shares moved down -0.28% in last trading session and ended the day on $7.06. SCLN Gross Margin is 84.70% and its return on assets is 12.80%. SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) quarterly performance is 34.73%.